SuperworthFulgent Genetics shares outstanding FLGT
Diluted shares outstanding, averaged over each quarter, from 2016.
- Latest quarter, to Jun 30, 2026
- 28M
- On a year earlier
- −8.3%
- fewer shares
Fulgent Genetics had 28M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 8.3% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 31M | +1% |
| FY2024 | 30.7M | +3% |
| FY2023 | 29.8M | +0% |
| FY2022 | 29.6M | −5% |
| FY2021 | 31.2M | +16% |
| FY2020 | 26.8M | +36% |
| FY2019 | 19.8M | +9% |
| FY2018 | 18.1M | +2% |
| FY2017 | 17.8M | +2% |
| FY2016 | 17.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 28M | −8% | |
| Q1 FY26 | 30.9M | +0% | |
| Q4 FY25 | 31M | +1% | |
| Q3 FY25 | 30.7M | +1% | |
| Q2 FY25 | 30.5M | +1% | |
| Q1 FY25 | 30.8M | +4% | |
| Q4 FY24 | 30.7M | +3% | |
| Q3 FY24 | 30.4M | +1% | |
| Q2 FY24 | 30.1M | +1% | |
| Q1 FY24 | 29.8M | +1% | |
| Q4 FY23 | 29.8M | +0% | |
| Q3 FY23 | 30M | −3% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Fulgent Genetics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.